Literature DB >> 21769711

Oral antidiabetic drug therapy in type 2 diabetes mellitus - focus on elderly patients.

Monika Lechleitner1.   

Abstract

The control of glycemia is of central importance in the therapy of patients with type 2 diabetes. This article summarizes the treatment options with respect to oral antidiabetic medication and with special consideration of elderly patients.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21769711     DOI： 10.1007/s10354-011-0914-6

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN： 0043-5341


  13 in total

1.  Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

Authors:  Anushka Patel; Stephen MacMahon; John Chalmers; Bruce Neal; Laurent Billot; Mark Woodward; Michel Marre; Mark Cooper; Paul Glasziou; Diederick Grobbee; Pavel Hamet; Stephen Harrap; Simon Heller; Lisheng Liu; Giuseppe Mancia; Carl Erik Mogensen; Changyu Pan; Neil Poulter; Anthony Rodgers; Bryan Williams; Severine Bompoint; Bastiaan E de Galan; Rohina Joshi; Florence Travert
Journal:  N Engl J Med       Date:  2008-06-06       Impact factor: 91.245

Review 2.  Management of type 2 diabetes: evolving strategies for the treatment of patients with type 2 diabetes.

Authors:  Ebenezer A Nyenwe; Terri W Jerkins; Guillermo E Umpierrez; Abbas E Kitabchi
Journal:  Metabolism       Date:  2011-01       Impact factor: 8.694

Review 3.  Metformin--the gold standard in type 2 diabetes: what does the evidence tell us?

Authors:  E Bosi
Journal:  Diabetes Obes Metab       Date:  2009-05       Impact factor: 6.577

4.  Glucose control and vascular complications in veterans with type 2 diabetes.

Authors:  William Duckworth; Carlos Abraira; Thomas Moritz; Domenic Reda; Nicholas Emanuele; Peter D Reaven; Franklin J Zieve; Jennifer Marks; Stephen N Davis; Rodney Hayward; Stuart R Warren; Steven Goldman; Madeline McCarren; Mary Ellen Vitek; William G Henderson; Grant D Huang
Journal:  N Engl J Med       Date:  2008-12-17       Impact factor: 91.245

5.  Effects of intensive glucose lowering in type 2 diabetes.

Authors:  Hertzel C Gerstein; Michael E Miller; Robert P Byington; David C Goff; J Thomas Bigger; John B Buse; William C Cushman; Saul Genuth; Faramarz Ismail-Beigi; Richard H Grimm; Jeffrey L Probstfield; Denise G Simons-Morton; William T Friedewald
Journal:  N Engl J Med       Date:  2008-06-06       Impact factor: 91.245

6.  Use of thiazolidinediones and fracture risk.

Authors:  Christian Meier; Marius E Kraenzlin; Michael Bodmer; Susan S Jick; Hershel Jick; Christoph R Meier
Journal:  Arch Intern Med       Date:  2008-04-28

7.  Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.

Authors:  Y Ohkubo; H Kishikawa; E Araki; T Miyata; S Isami; S Motoyoshi; Y Kojima; N Furuyoshi; M Shichiri
Journal:  Diabetes Res Clin Pract       Date:  1995-05       Impact factor: 5.602

8.  Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

9.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

10.  Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women.

Authors:  Thomas A Buchanan; Anny H Xiang; Ruth K Peters; Siri L Kjos; Aura Marroquin; Jose Goico; Cesar Ochoa; Sylvia Tan; Kathleen Berkowitz; Howard N Hodis; Stanley P Azen
Journal:  Diabetes       Date:  2002-09       Impact factor: 9.461
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.